Evolutionary dynamics of two related malignant plasma cell lines

Area of Science:

• Oncology
• Evolutionary Biology
• Mathematical Modeling

Background:

• Cancer arises from accumulated somatic cell mutations, leading to clonal evolution driven by selection.
• Cancer therapies can exert selective pressures, favoring or disfavoring specific tumor cell subclones.
• Tumor heterogeneity and clonal interactions are critical determinants of disease progression and treatment response.

Purpose of the Study:

• To investigate the evolutionary dynamics between two distinct cell lines from the same patient at different disease stages.
• To elucidate the relationship and interactions between coexisting tumor subclones.
• To understand how therapeutic interventions influence clonal selection and disease trajectory.

Main Methods:

• In vitro studies utilizing patient-derived cell lines.
• Mathematical modeling to simulate and analyze clonal evolutionary dynamics.
• Comparative analysis of cell lines isolated at different time points of disease progression.

Main Results:

• Evidence of coexistence of two distinct clones at initial disease presentation.
• Initial therapy selected for a minor clone, leading to its expansion and a diagnostic shift.
• Demonstrated a transition from cardiac AL amyloidosis to multiple myeloma due to clonal selection.

Conclusions:

• Therapeutic interventions can significantly alter tumor clonal composition and evolutionary trajectories.
• Understanding clonal dynamics is crucial for predicting treatment outcomes and disease progression.
• The study provides insights into shared phenotypic characteristics and their potential mechanisms between distinct cancer clones.